Navigation Links
Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
Date:4/18/2008

VANCOUVER, April 18 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today reported that its corporate partner, Boston Scientific Corporation "BSC" (NYSE: BSX) has received approval for the sale of its TAXUS Liberte paclitaxel-eluting coronary stent system in Canada. BSC reported that Health Canada's Therapeutic Products Directorate (TPD), the authority that regulates pharmaceutical drugs and medical devices, has approved its use. BSC said it plans to launch the product immediately in Canada.

"The TAXUS Liberte Stent is a major advance in stent development and raises the bar for drug-eluting stent systems," said Serge Doucet, M.D., Cathlab Director at the Montreal Heart Institute. "It offers enhanced ability to conform to the vessel wall and deliver across some of the most challenging lesions. This innovation is welcome news for interventional cardiologists and patients in Canada who suffer from coronary artery disease."

"As Boston Scientific develops new platforms, we are excited to see that our technology continues to be leveraged in the next-generation of drug-eluting stents and pleased that Canadian physicians and patients can now benefit from the TAXUS Liberte for the treatment of coronary artery disease," said Dr. William Hunter, President and CEO of Angiotech.

Currently the leading drug-eluting stents worldwide, TAXUS Stent Systems have been evaluated by the industry's most extensive randomized, c
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Vical Names Andrew de Guttadauro Vice President, Corporate Development
4. Signalife Provides Corporate Update
5. Biomira Announces Plan to Reincorporate in the United States
6. Pressure BioSciences, Inc. Provides Corporate Update
7. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
8. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
9. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008).... 13 /- Proteon Therapeutics is,prese...clinical,demonstration of the potential of PRT-201...wer limb peripheral arterial disease (PAD). The,pr...stase Therapy: A Novel,Approach to Vessel Dilation... Transcatheter Cardiovascular Therapeutics (TCT) s...
(Date:10/13/2008)..., Oct. 13 /- WebLOQ, Inc., the emergi...d compliant eBusiness and,data-in-motion communica...nt has deployed the WebLOQ ePrivacy solution in th...along with their healthcare partner, the,Monterey ...s, has,implemented WebLOQ,s hosted, on demand ePri...
(Date:10/13/2008)...Oct. 13 /Xinhua-- Pharmaxis...tember 2008 Quarterly,Report to Shareholders on th...ertson will host an investor teleconference the fo...nvestor questions., The teleconference will be on...day 15th October at 5.30pm U.S. East Coast, 2.30pm...
(Date:10/10/2008)... /- CorMatrix Cardiovascular, Inc., a...d delivering unique,extracellular matrix (ECM(TM))...e ability to repair damaged cardiovascular tissue,...ef Scientific Officer, will present data,on the co...annual,Transcatheter Cardiovascular Therapeutics (...
Breaking Biology Technology:Proteon Therapeutics to Present New Data on PRT-201 at Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium in Washington, D.C., October 13, 2008 2Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange 2Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange 3CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C. 2
...n Gov. Jim Doyle , noting that May 24 is the one-...gislation to overturn President Bush,s ban on fe...id Congressional inaction is delaying critical sci...rity Leader Bill Frist , R-Tennessee, has yet to ...on the Stem Cell Research Enhancement Act (HR 810)...
... English will become the official language of the ...p soccer tournament beat them to it. , ,For the f... will have to show proficiency in written and spok...aking part in soccers global tournament this summe...its called in most of the world. But when it comes...
...cellent adventure is entering a new phase. Both ar...S. Federal Government. It took nearly four years b...ng - were found guilty as charged last week by a t...nians. The duo will soon be sentenced before headi..., , When Creative Becomes Criminal , ,It is easy...
...nt company of a Florida manufacturer of radio freq...y nature of the product following the signing of a...nt agencies from requiring them to be implanted. ,...ital, the parent of VeriChip Corp., said the compa...ovides. "In theory, we,re in agreement with the bi...
Other Biology Technology:English as the lingua franca of a new age: Its more powerful than any law 2English as the lingua franca of a new age: Its more powerful than any law 3Are there more Enrons out there? 2Are there more Enrons out there? 3Are there more Enrons out there? 4Company defends RFID implant product 2
(Date:10/10/2008)... a previously unknown relationship between stem ce...ndria a cell,s energy makers. Stem cells with more...to differentiate and are more likely to form tumor..., could lead to methods of enriching the best stem...ay provide some insights into the role of stem cel...
(Date:10/10/2008)..., MADISON Governor Jim Doyle today announced a hi...ch institutions to advance personalized health car...s diseases. The Wisconsin Genomics Initiative is a...d Clinic, Medical College of Wisconsin (MCW), Univ...Health (UWSMPH) and UW-Milwaukee (UWM). , Wiscon...
(Date:10/10/2008)...g the 1950s, Austrian and Swiss scientists conduct...l taking photographs of the glaciers, mountains an...ogist Fritz Mller spent eight months in the region...ographing the Himalayan glaciers. , Now, fifty y...by these scientists are of immense value in trying...
(Date:10/10/2008)...ble in German . , DNA, the molecule that acts...s of life, is highly resistant against alteration ...ism for its photostability presents some puzzling ...the four chemical bases that make up the DNA molec... in showing that DNA strands differ in their light...
Breaking Biology News(10 mins):Governor Doyle announces historic genomic research collaboration 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3Can genetic information be controlled by light? 2Forest Laboratories Inc and Gedeon Richter Announce Results of Phase II B Study for RGH 188 as a Treatment for Schizophrenia 519 1Forest Laboratories Inc and Gedeon Richter Announce Results of Phase II B Study for RGH 188 as a Treatment for Schizophrenia 519 2Forest Laboratories Inc and Gedeon Richter Announce Results of Phase II B Study for RGH 188 as a Treatment for Schizophrenia 519 3Forest Laboratories Inc and Gedeon Richter Announce Results of Phase II B Study for RGH 188 as a Treatment for Schizophrenia 519 4After drought ponds keep up with the Joneses 808 1After drought ponds keep up with the Joneses 808 2After drought ponds keep up with the Joneses 808 3Studies Examine Life After Weight Loss Surgery 3715 1Studies Examine Life After Weight Loss Surgery 3715 2Studies Examine Life After Weight Loss Surgery 3715 3Studies Examine Life After Weight Loss Surgery 3715 4Baxter International Third Quarter 2007 Financial Results Conference Call 3712 1
...sults from a new study in laboratory mice show tha...d the growth of human breast tumors by suppressing... study also showed that extended periods of nightt...mors. , The study results might explain why female...cancer. It also offers a promising new explanation...
...ung adults with high levels of antibodies against ...causes mononucleosis, may be more likely to develo...ng to a study posted online today that will appear...logy, one of the JAMA/Archives journals. , Researc... influence the risk for multiple sclerosis (MS), a...
...ung adults with high levels of antibodies against ...causes mononucleosis, may be more likely to develo...ng to a study posted online today that will appear...logy, one of the JAMA/Archives journals. , Researc... influence the risk for multiple sclerosis (MS), a...
...search studies, based at the University of Pennsyl...es containing two potent cancer-fighting drugs are...ique properties of the hollow shell nano-particles... distinct drugs, paclitaxel, the leading cancer dr...icin directly to tumors implanted in mice. Their ...
Other Biology News:New Research Shows Artificial Light at Night Stimulates Breast Cancer Growth in Laboratory Mice 2New Research Shows Artificial Light at Night Stimulates Breast Cancer Growth in Laboratory Mice 3Big hips, big belly? It's in your genes, Joslin-led study shows 2Epstein-Barr virus may be associated with multiple sclerosis 2Nano-particles effective in killing cancer with one-two punch of chemotherapeutics 2
Lipid-rich bovine serum albumin for cell culture. It is chromatographically purified and has an IgG content 1.0% (w/w).
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L.
Request Info
Bsg I from New England Biolabs
Biology Products: